A Randomized, Open label, Pharmacokinetic study to evaluate the bioavailability of nasally administered naloxone formulations to Narcan nasal spray
Phase of Trial: Phase I
Latest Information Update: 06 Jan 2019
Price : $35 *
At a glance
- Drugs Naloxone (Primary)
- Indications Opioid abuse
- Focus Therapeutic Use
- 06 Jan 2019 Results presented in the Orexo media release.
- 25 Oct 2018 According to an Orexo media release, the company anticipates to initiate this trial in Q4, 2018.
- 13 Jul 2018 New trial record